Tenax Therapeutics Eulerpool Novinky

Tenax Therapeutics Eulerpool News

Tenax Therapeutics Novinky o akciách

Tenax Therapeutics sledujú mnohí novinári a investori po celom svete. Najaktuálnejšie správy Tenax Therapeutics zhromažďujeme práve tu.

• 20. mája ·

  Yahoo
  TENX: First Quarter Results
• 14. mája ·

  InvestorPlace
  TENX Stock Earnings: Tenax Therapeutics Misses EPS for Q1 2024
• 14. mája ·

  Yahoo
  Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
• 14. mája ·

  Seeking Alpha
  Tenax Therapeutics GAAP EPS of -$3.12
• 14. mája ·

  Thefly.com
  Tenax Therapeutics reports Q1 EPS ($3.12) vs. ($12.10) last year
• 30. apríla ·

  Yahoo
  Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
• 30. apríla ·

  Thefly.com
  Tenax Therapeutics announces new U.S. patent covering use of levosimendan
• 18. apríla ·

  InvestorPlace
  Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
• 18. apríla ·

  Benzinga
  Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
• 9. apríla ·

  Yahoo
  Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”